8
report
New Models for Financing Translational Medical Research in Singapore
Adapting scientific lab discoveries into life-saving drugs for commercial consumption is no small f
eat. Often times medical research stalls when drugs get to the translational stage of the process.
+ Read More
report
New Models for Financing Translational Medical Research in Singapore: Update
Since 2017, the Milken Institute has engaged with stakeholders worldwide on new models for financin
g translational biomedical research in Singapore.
+ Read More
article
Fact or Fantasy? The Promise Of A Genomics Health-Care Revolution
Imagine a future world in which we prevent disease before it develops, remove trial-and-error from t
reatment, and trust that our doctors have all the information they need to treat us as unique individuals. That is the promise of genomic medicine.,
An estimated 65 million human genomes are expected to be sequenced by 2025.
, Take, for example, a critically ill baby in intensive care where doctors are struggling to find a diagnosis.
+ Read More
article
Does it Work for Patients? A Multi-Step Approach to Defining Performance and Measuring Progress Across the Biomedical Ecosystem
Quick Links
Step One: Discover Existing Research »
Step Two: Articulate Ideals»
Step Three: Ident
ify Measures »
+ Read More
article
Pediatric Biomarkers: A Slow Zone for Patients
Q. When it comes to oncology, what is one specific example of how the system is not performing well
for patients, in other words, a Slow Zone?
+ Read More
article
Patient Organizations as Research and Data Partners
What data assets are patient organizations creating, and how are they adding value to the work of pa
rtners trying to accelerate therapeutic development for patients?
+ Read More
video
Advances in Science: A Decade of Progress in Alzheimer’s Disease Research
Rajiv Ahuja, associate director at the Milken Institute, focusing on the future of aging, moderate
s this Advances in Science webinar with featured guest Richard J.
+ Read More